Preview

Title in english

Advanced search

Biochemical abnormalities among patients from 0 to 3 years old with COVID-19 as a sign of subclinical forms of multisystem inflammatory syndrome in children

https://doi.org/10.34680/2076-8052.2022.1(126).52-55

Abstract

While studying COVID-19 cases among children, one of the most important areas is the study of the multisystem inflammatory syndrome in children. This study aims to analyze the biochemical parameters of blood serum in children from 0 to 3 years old, that is, belonging to the age group atypical for the development of a clinically manifest multisystem inflammatory syndrome. It has been revealed that more than a half of the subjects have abnormalities in the biochemical parameters of blood serum corresponding to laboratory markers of the multisystem inflammatory syndrome in children, which indicates the possibility of the development of subclinical forms of this syndrome, associated in time with COVID-19, in children of different age groups. The results of the study substantiate the need for further investigation of biochemical parameters in children of different ages and for finding a solution to the issue of dynamic monitoring of children with identified abnormalities, taking into account the possibility of long-term impact of SARSCoV-2 on the organs and systems of a child's body.

About the Authors

A. N. Denisenko
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation


A. S. Denisenko
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation


M. E. Riss
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation


L. D. Filina
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation


References

1. Ramcharan T., Nolan O., Lai C.Y. et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol, 2020, 41, pp. 13911401.

2. Cantor A., Miller J., Zachariah P.et al. Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center Report. Hepatology, 2020, 72(5), pp. 1522-1527.

3. Valverde I., Singh Y., Sanchez-de-Toledo J., et al. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe. Circulation, 2021 Jan 5, 143(1), pp. 21-32.

4. Whittaker E., Bamford A., Kenny J., et al. Clinical Characteristics of 58 Children with a Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARSCoV-2. JAMA, 2020 Jul 21, 324(3), pp. 259-269.

5. Caro-Domínguez P., Navallas M., Riaza-Martin L. et al. Imaging findings of the multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Radiol, 2021, 51, pp. 1608-1620.

6. Bohn M.K., Lippi G., Horvath A., et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clinical Chemistry and Laboratory Medicine (CCLM), 2020, vol. 58, no. 7, pp. 1037-1052.

7. Das K.M., Singh R., Subramanya S., Ojha S.K., et al. Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19. Future Virology, 2021, 16(9), pp. 601-609.


Review

For citations:


Denisenko A.N., Denisenko A.S., Riss M.E., Filina L.D. Biochemical abnormalities among patients from 0 to 3 years old with COVID-19 as a sign of subclinical forms of multisystem inflammatory syndrome in children. Title in english. 2022;(1(126)):52-55. (In Russ.) https://doi.org/10.34680/2076-8052.2022.1(126).52-55

Views: 47


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2076-8052 (Print)